ClinicalTrials.gg
CompletedNCT06761001Updated Feb 19, 2025

Investigation of the Effect of I-PRF Application on Pain in Alveolitis

An interventional study of I-PRF and Control in Alveolar Osteitis, Pain and Dry Socket, sponsored by Eskisehir Osmangazi University. Completed at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-19.

Sponsored by Eskisehir Osmangazi University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Literature review showed that there are no studies on the use of i-PRF in alveolitis cases. The aim of this study was to investigate the effect of i-PRF on the treatment of alveolitis. The hypothesis of the study was that i-PRF applied to alveolitis patients would reduce pain.

Read the detailed description

The present study will include 60 healthy patients over 18 years of age with alveolitis. 60 patients will be randomly divided into two groups: Control and I-PRF. After irrigation of the sockets, no substance will be applied to the control group, and I-PRF will be applied to the study group. Postoperative pain will be measured on the 3rd and 7th days.

02

Conditions studied

  • Alveolar Osteitis
  • Pain
  • Dry Socket

Browse trials for

Keywords

  • injectable platelet rich fibrine
03

In context

Dry Socket

46 studies on the registry are indexed under Dry Socket; 10 are open to participants now.

This study's enrollment of 60 is close to the median of 60 across 41 interventional studies indexed under Dry Socket.

Browse Dry Socket studies →

Lead sponsor

Eskisehir Osmangazi University is the lead sponsor of 153 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Healthy individuals without systemic disease Patients with complete data and attending their appointments

Exclusion criteria

Exclusion Criteria:

Patients who smoke Pregnant or breastfeeding female patients with bleeding disorders and diabetics Patients currently or previously using bisphosphonates or receiving radiotherapy to the jaw Patients unable to consent to participate in the study

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    I-PRF

    I-PRF Application

    Device: I-PRF

  • Active comparator
    Standard treatment

    standard treatment

    Other: Control

Interventions

  • DeviceI-PRF

    After local anesthesia is injected, alveolar curettage is performed and the socket is irrigated with saline solution. I-PRF is given to patients in the experimental group.

  • OtherControl

    After local anesthesia is injected, alveolar curettage is performed and the socket is irrigated with saline solution.

06

What researchers measure

Primary outcomes

  1. Change in post-operative pain assessed: visual analog (VAS) scale

    VAS measured on a 10cm scale, where 0 represents no pain and 10 represents maximum pain

    Time frame: postoperative 3rd, and 7th days

07

Study locations

1 site
  • Eskişehir Osmangazi University
    Eskişehir, 26480, Turkey
08

References and documents

Publications

  • Uranbey O, Ayranci F. How effective are concentrated growth factor and injectable platelets in reducing complications following impacted third molar surgery? Quintessence Int. 2024 May 30;55(5):380-390. doi: 10.3290/j.qi.b5213477. PubMed 38619256 ↗
  • Laforgia A, Inchingolo AD, Riccaldo L, Avantario P, Buongiorno S, Malcangi G, Bordea IR, Palermo A, Inchingolo F, Inchingolo AM, Dipalma G. The Use of Platelet-Rich Fibrin (PRF) in the Management of Dry Socket: A Systematic Review. Int J Mol Sci. 2024 Sep 19;25(18):10069. doi: 10.3390/ijms251810069. PubMed 39337554 ↗
  • Sharma A, Aggarwal N, Rastogi S, Choudhury R, Tripathi S. Effectiveness of platelet-rich fibrin in the management of pain and delayed wound healing associated with established alveolar osteitis (dry socket). Eur J Dent. 2017 Oct-Dec;11(4):508-513. doi: 10.4103/ejd.ejd_346_16. PubMed 29279679 ↗

Individual participant data

Plan to share: No — IPD may share with other researchers upon request

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06761001
Responsible party
Gorkem Tekin (Asst.Prof., Eskisehir Osmangazi University) — Principal investigator
First posted
Jan 7, 2025
Start date
Oct 20, 2024
Primary completion
Feb 18, 2025
Completion
Feb 18, 2025
Last update
Feb 19, 2025

Study contacts

Görkem TEKİN, Assist.Prof.
study chair · Eskişehir Osmangazi University Faculty of Dentistry

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion